Internal Medicine, Hematology & Oncology · Boise, ID
NPI
1821010455
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
100 E Idaho St
Boise, ID, 83712
Phone (208) 381-2709
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
604 services
Medicare patients, 2024
150
Average age 73
Drug cost, 2024
$5.7M
819 prescriptions
Company payments, 2025
$249
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William H Kreisle was code 99214 (office e&m - established), 165 times for 90 patients. In total William H Kreisle billed 604 services in 25 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-03-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 165 | 90 | $62.46 | $10K |
| 99215 Office E&M - Established | Facility | 124 | 41 | $103.96 | $13K |
| 99233 Hospital E&M - Subsequent | Facility | 107 | 27 | $83.10 | $8,892 |
| 99232 Hospital E&M - Subsequent | Facility | 43 | 17 | $57.36 | $2,466 |
| G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 29 | 13 | $22.28 | $646 |
| 99223 Hospital E&M - Initial | Facility | 25 | 16 | $120.85 | $3,021 |
| 99239 Hospital Discharge Management | Facility | 25 | 17 | $83.82 | $2,096 |
| 99213 Office E&M - Established | Facility | 11 | 11 | $38.96 | $429 |
By year: 2022 $28K for 387 services; 2023 $26K for 339 services; 2024 $46K for 604 services.
Medicare prescription drug claims, 2024
In 2024, the drug William H Kreisle prescribed most often to Medicare patients was Revlimid (Lenalidomide), with 135 prescriptions and refills. In total William H Kreisle wrote 819 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Revlimid Lenalidomide | 135 | 135 | 13 | $2.8M |
| Acyclovir Generic | 112 | 257 | 45 | $4,391 |
| Jakafi Ruxolitinib Phosphate | 52 | 52 | Under 11 | $833K |
| Venclexta Venetoclax | 31 | 31 | Under 11 | $306K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 30 | 47 | 13 | $259 |
| Dexamethasone Generic | 28 | 46 | 13 | $631 |
| Ondansetron Odt Ondansetron | 21 | 21 | 16 | $413 |
| Calquence Acalabrutinib Maleate | 21 | 21 | Under 11 | $243K |
| Levofloxacin Generic | 20 | 22 | 13 | $368 |
| Lenalidomide Generic | 19 | 19 | Under 11 | $214K |
| Ninlaro Ixazomib Citrate | 18 | 18 | Under 11 | $214K |
| Brukinsa Zanubrutinib | 18 | 18 | Under 11 | $250K |
| Tretinoin Generic | 17 | 17 | Under 11 | $27K |
| Potassium Chloride Generic | 15 | 33 | 11 | $304 |
| Imatinib Mesylate Generic | 14 | 18 | Under 11 | $6,786 |
Brand drugs: 351 claims; generic drugs: 468 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William H Kreisle $249 ($249 in general payments such as food, travel and fees) from 6 companies. The largest payer was Incyte Corporation with $149.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.